Raphael Chagas Silva

Mr. Raphael Chagas Silva

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2022 in Clinical & Experimental Allergy
Verified
Journal Article
Closed access
Antônio Márcio Santana FernandesAntônio Márcio Santana Fernandes
Antônio Márcio Santana Fernandes
Eduardo Santos da SilvaEduardo Santos da Silva
Eduardo Santos da Silva
ESElisânia Fontes Silveira
Elisânia Fontes Silveira
EBEmília Maria Maria Medeiros de Andrade Belitardo
Emília Maria Maria Medeiros de Andrade Belitardo
LSLeonardo Freire Santiago
Leonardo Freire Santiago
CPCARINA DA SILVA PINHEIRO
CARINA DA SILVA PINHEIRO

13 February 2023 in Clinical & Experimental Allergy
Verified
Journal Article
Closed access
Eduardo Santos da SilvaEduardo Santos da Silva
Eduardo Santos da Silva
MSMarina Borges Rabelo de Santana
Marina Borges Rabelo de Santana
ESElisânia Fontes Silveira
Elisânia Fontes Silveira
RTRogério Tanan Torres
Rogério Tanan Torres
RSRaphael Chagas Silva
Raphael Chagas Silva
NANeuza Maria Alcantara-Neves
Neuza Maria Alcantara-Neves

14 March 2022 in Experimental and Applied Acarology
Verified
Journal Article
Closed access
PDF file
VAVítor S. Alves
Vítor S. Alves
FSFabián Salazar-Garcés
Fabián Salazar-Garcés
LSLeonardo F. Santiago
Leonardo F. Santiago
Paula FonsecaPaula Fonseca
Paula Fonseca
Antônio Márcio Santana FernandesAntônio Márcio Santana Fernandes
Antônio Márcio Santana Fernandes
CPCARINA DA SILVA PINHEIRO
CARINA DA SILVA PINHEIRO

17 December 2025 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
COCarolina Melo Orrico-Ferreira
Carolina Melo Orrico-Ferreira
PCPaulo Emilio Oliveira Cruz
Paulo Emilio Oliveira Cruz
JRJoao Vitor Borges Rios
Joao Vitor Borges Rios
WRWellington da Silva Rosa
Wellington da Silva Rosa
BSBeatriz de Souza Santos
Beatriz de Souza Santos
BFBarbara Castro-Pimentel Figueiredo
Barbara Castro-Pimentel Figueiredo
Schistosoma mansoni initiates infection through active skin penetration by cercariae, triggering early immune responses that are crucial to disease establishment. In naïve hosts, parasite antigens elicit an initial Th1-type response that is rapidly modulated to a Th2 profile by parasite-derived immunomodulatory molecules, including proteases and eicosanoids. Upon reinfection, prior sensitization enhances Th2 responses, IgE production, and eosinophil recruitment, while promoting regulatory mechanisms that limit pathology and favor chronic infection. Key molecules such as cercarial elastase (SmCE) interfere with antigen presentation and antibody function, facilitating immune evasion. This review explores the early immune responses elicited at the cutaneous interface during primary S. mansoni infection and reinfection, emphasizing the dynamic interplay between host defense mechanisms and parasite-driven immunoregulation. Understanding these early skin-stage events reveals how S. mansoni balances immune activation and suppression, offering valuable targets for vaccine development and immune-based interventions.

18 September 2023 in Allergies
Verified
Journal Article
Open access
PDF file
CVCamilo J. B. Vieira
Camilo J. B. Vieira
RSRaphael Chagas Silva
Raphael Chagas Silva
ESElisania Fontes Silveira
Elisania Fontes Silveira
Antônio Márcio Santana FernandesAntônio Márcio Santana Fernandes
Antônio Márcio Santana Fernandes
Dumar A. Jaramillo-HernándezDumar A. Jaramillo-Hernández
Dumar A. Jaramillo-Hernández
Eduardo Santos da SilvaEduardo Santos da Silva
Eduardo Santos da Silva
(1) Background: Modification of the structural elements of allergens is widely used in the field of allergies. The goal of the present research was to express, purify, and characterize the shortened recombinant group 5 allergen of Dermatophagoides pteronyssinus (rDer p 5). (2) Methods: rDer p 5 storage stability and aggregation capacity were explored through in silico analysis, dynamic light scattering (DLS), and SDS-PAGE. Serum IgE reactivity and cytokine amount were investigated in sera or cell culture supernatants through ELISA, MULTIPLEX®, and Western blot analysis using sera from sensitized humans from Brazil, Colombia, and Ecuador. (3) Results: Dimeric rDer p 5 was detected through native PAGE, and this result was confirmed by data from DLS. The protein was thermically stable, as it did not degrade at 4 °C for 21 days. The shortened rDer p 5 was classified as a major IgE allergen in Brazil and Colombia, but minor in Ecuador. IL-13, IL-10, IL-1β, and IL-6 were significantly elevated in the sera of rDer p 5-reactive patients. The same cytokines plus IL-5 were more secreted by human cells upon rDer p 5 stimulation. (4) Conclusions: N-terminal peptide deletion led to a higher rDer p 5 folding stability, which, even though dimeric, was an IgE-reactive protein. Therefore, rDer p 5 could be used for molecular diagnostic applications or as backbone for hypoallergen design.

21 February 2025 in Acta Tropica
Verified
Journal Article
Closed access
LSLeonardo F. Santiago
Leonardo F. Santiago
Eduardo Santos da SilvaEduardo Santos da Silva
Eduardo Santos da Silva
PSPriscila S. dos Santos
Priscila S. dos Santos
LGLuis F. Salazar- Garcés
Luis F. Salazar- Garcés
SSSara P.O. Santos
Sara P.O. Santos
CPCARINA DA SILVA PINHEIRO
CARINA DA SILVA PINHEIRO